A practical guideline of genomics-driven drug discovery in the era of global biobank meta-analysis.

ABSTRACT: Genomics-driven drug discovery is indispensable for accelerating the development of novel therapeutic targets. However, the drug discovery framework based on evidence from genome-wide association studies (GWASs) has not been established, especially for cross-population GWAS meta-analysis. Here, we introduce a practical guideline for genomics-driven drug discovery for cross-population meta-analysis, as lessons from the Global Biobank Meta-analysis Initiative (GBMI). Our drug discovery framework encompassed three methodologies and was applied to the 13 common diseases targeted by GBMI (N _mean = 1,329,242). Individual methodologies complementarily prioritized drugs and drug targets, which were systematically validated by referring previously known drug-disease relationships.

SUBMITTER: Namba S 

PROVIDER: S-EPMC9903693 | biostudies-literature | 2022 Oct

REPOSITORIES: biostudies-literature